BackEucrates Biomedical Acquisition Overview

Eucrates Biomedical Acquisition Other Current Assets

Eucrates Biomedical Acquisition's other current assets is $0.

Get informed when a big investor buys or sells

+ Follow
Other Current Assets
$0.00
↓ 100.00% YoYΔ $-215000.00 vs prior year quarter

Peer average / median

Loading

Eucrates Biomedical Acquisition Other Current Assets History

Loading

Eucrates Biomedical Acquisition vs. peers: Other Current Assets Comparison

Loading

Eucrates Biomedical Acquisition Other Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Eucrates Biomedical Acquisition (EUCR) FAQ

As of the most recent data (December 2022), EUCR shows a other current assets of $0. That compares with $220K in the prior-year period — down 100.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, EUCR's other current assets is now $0 (was $220K) — a 100.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Eucrates Biomedical Acquisition is outperforming or lagging.

Tracking EUCR's other current assets over time shows whether Eucrates Biomedical Acquisition is scaling, shrinking, or reshaping that part of the business. The current reading is $0 That compares with $220K in the prior-year period — down 100.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current assets page, Stockcircle has Eucrates Biomedical Acquisition's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current assets (currently $0) with ownership activity and broader fundamentals.